TL;DR
Get health and wellness essentials delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
A USC-led study found that older adults with mesial temporal lobe epilepsy tended to have more abnormal immature astroglia in hippocampal tissue, and higher counts were associated with poorer fluid intelligence. The small study does not establish that the cells cause cognitive difficulties or show whether the findings apply beyond this patient group.
A USC-led study of 29 people with mesial temporal lobe epilepsy found that older patients tended to have more abnormal immature astroglia in tissue removed from the hippocampus, while higher numbers of those cells were associated with poorer fluid intelligence—the ability to reason through unfamiliar problems. The findings, published in Frontiers in Cellular Neuroscience, show an association, not that the cells cause cognitive decline.
The researchers examined tissue taken from the patients’ hippocampi during surgery to treat severe, drug-resistant seizures. Before their operations, patients completed cognitive tests covering reasoning, memory, attention, language and fine motor coordination. Researchers later identified and counted immature astroglia in selected areas of the tissue and compared the counts with the test results.
The team reported two related observations: older patients tended to have more abnormal immature astroglia, and patients with higher numbers of these cells performed less well on fluid-intelligence tests. Fluid intelligence refers to solving new problems, rather than relying only on information learned previously. The report does not provide a numerical effect size in the supplied study summary.
The work was supported in part by the National Institutes of Health. Aswathy Ammothumkandy, the study’s first author and an assistant professor of research at the Keck School of Medicine of USC, said the results suggest astroglia could be relevant to cognition and merit further study. The researchers say more evidence is needed to determine whether the cells contribute directly to cognitive changes.
Why Astroglia Matter to Cognition
Astroglia are star-shaped brain cells generally understood to support neurons and help maintain a healthy environment for brain activity. They have received less attention as potential contributors to cognition than neurons. The study’s significance lies in its use of human brain tissue paired with cognitive testing, rather than relying only on animal experiments or indirect measures such as gene activity.
If future research confirms that particular astroglia states play a part in cognitive decline, the cells or their molecular features could offer researchers new avenues for treatment research. That possibility could matter for people with epilepsy and perhaps for other conditions linked to cognitive impairment or aging. This study does not test a treatment, establish a mechanism, or show that changing astroglia improves thinking. Its findings are an early lead, not evidence that a therapy is available or effective.
As an affiliate, we earn on qualifying purchases.
How Researchers Studied the Cells
Studying individual cell types in living human brains is difficult. The source report says non-invasive methods such as electroencephalography and magnetic resonance imaging generally cannot resolve individual cells in the way microscopic examination can. Researchers also rarely have access to tissue from living patients. In this case, tissue was available because it had been removed as part of treatment for drug-resistant mesial temporal lobe epilepsy.
The hippocampus is involved in learning and memory, and epilepsy in this patient group can involve seizures and cognitive difficulties. The researchers used assessments completed before surgery and tissue examined afterward, allowing them to compare cell counts with patients’ cognitive performance. The patients were not described as a representative sample of older adults generally: they were people receiving surgery for a serious form of epilepsy.
The study builds on a research area in which astroglia have traditionally been viewed as support cells that help neurons communicate and sustain brain conditions. Earlier work on astroglia and cognition has relied mainly on animal models or indirect indicators, according to the report. The USC team says direct measurements in human tissue offer a different kind of evidence, while the clinical setting and limited sample size constrain how broadly the result can be applied.
“Higher numbers of these cells were also associated with poorer performance on tests of fluid intelligence.”
— Aswathy Ammothumkandy, the study’s first author
As an affiliate, we earn on qualifying purchases.
Limits of the Patient Findings
The study establishes an association in a group of 29 surgical patients; it does not establish whether abnormal immature astroglia contribute to lower fluid intelligence, arise alongside other brain changes, or reflect another factor. The report also does not provide enough detail here to quantify the strength of the association or determine how the results varied among individual patients.
It remains unclear whether the findings apply to people without epilepsy, to other forms of epilepsy, or to conditions such as Parkinson’s disease, frontotemporal dementia and multiple sclerosis. Those disorders are mentioned as conditions in which fluid intelligence may be impaired, not as populations examined in this study. No drug or neuromodulation treatment was evaluated, and the researchers have not shown that altering astroglia improves cognitive performance.
cognitive testing tools for adults
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Research Aims for Astroglia
Ammothumkandy is investigating molecular differences in immature astroglia, comparing cells from people with epilepsy with control samples. The aim is to better characterize the cells and identify features that might point to possible drug targets. The source report does not give a timetable for those studies or describe a planned clinical trial.
Future work may also explore whether approaches such as neuromodulation—electrical or magnetic stimulation intended to alter nervous-system activity—can support healthy astroglia function. For now, the next step is further research to test whether the association can be reproduced and to clarify whether astroglia have a causal role. Any treatment implications remain prospective.
As an affiliate, we earn on qualifying purchases.
Key Questions
What did the study find?
In 29 people with mesial temporal lobe epilepsy, older patients tended to have more abnormal immature astroglia in hippocampal tissue. Higher cell counts were associated with poorer fluid-intelligence test performance.
Does the study prove astroglia cause cognitive decline?
No. The study reports an association between cell counts and test results. It does not show that astroglia caused the lower scores or that changing the cells would improve cognition.
Who took part in the research?
The study examined tissue from 29 patients with mesial temporal lobe epilepsy whose hippocampal tissue was surgically removed to help treat severe, drug-resistant seizures.
Could the findings lead to a treatment?
The researchers see astroglia as a possible future research target and are investigating molecular differences in the cells. No treatment was tested, and there is no evidence from this study that an astroglia-based therapy is available or effective.
Do the results apply to people without epilepsy?
That is not known. The participants had epilepsy and were undergoing brain surgery, so further studies are needed before the findings can be extended to other groups.
Source: rss
Cold & flu season Picks
humidifiers
As an affiliate, we earn on qualifying purchases.
